We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
-14.21%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$89.1B
AUM Growth
+$88.9B
Cap. Flow
-$3.22B
Cap. Flow %
-3.61%
Top 10 Hldgs %
11.59%
Holding
2,672
New
86
Increased
706
Reduced
853
Closed
108

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$504M
2
AAPL icon
Apple
AAPL
+$433M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$248M
4
VTRS icon
Viatris
VTRS
+$241M
5
AMZN icon
Amazon
AMZN
+$210M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.43%
3 Financials 13.5%
4 Industrials 10.21%
5 Consumer Discretionary 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SONO icon
1301
Sonos
SONO
$1.87B
$1.77M ﹤0.01%
98,294
+31,188
+46% +$699K
AMKR icon
1302
Amkor Technology
AMKR
$15B
$1.77M ﹤0.01%
104,255
OFG icon
1303
OFG Bancorp
OFG
$2.21B
$1.76M ﹤0.01%
69,200
+8,500
+14% +$228K
CC icon
1304
Chemours
CC
$2.55B
$1.75M ﹤0.01%
54,616
CDMO
1305
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1.74M ﹤0.01%
114,182
+552
+0.5% +$8.16K
UVV icon
1306
Universal Corp
UVV
$1.34B
$1.74M ﹤0.01%
28,707
-3,517
-11% -$210K
NVR icon
1307
NVR
NVR
$16.9B
$1.73M ﹤0.01%
431
-4
-0.9% -$17K
MTB icon
1308
M&T Bank
MTB
$36B
$1.73M ﹤0.01%
10,821
+2,906
+37% +$488K
KPTI icon
1309
Karyopharm Therapeutics
KPTI
$161M
$1.72M ﹤0.01%
25,469
BUSE icon
1310
First Busey Corp
BUSE
$2.52B
$1.72M ﹤0.01%
75,077
WNC icon
1311
Wabash National
WNC
$538M
$1.71M ﹤0.01%
126,196
+1,320
+1% +$19.1K
FUTU icon
1312
Futu Holdings
FUTU
$14.6B
$1.71M ﹤0.01%
32,704
+4,461
+16% +$168K
TX icon
1313
Ternium
TX
$9.37B
$1.7M ﹤0.01%
47,180
FFIV icon
1314
F5
FFIV
$23B
$1.7M ﹤0.01%
11,085
+1,010
+10% +$176K
ALLO icon
1315
Allogene Therapeutics
ALLO
$604M
$1.69M ﹤0.01%
148,469
NTNX icon
1316
Nutanix
NTNX
$15.4B
$1.68M ﹤0.01%
114,619
-133,126
-54% -$2.77M
NBIS
1317
Nebius Group N.V.
NBIS
$47.7B
$1.68M ﹤0.01%
1,425,570
-60,752
-4% -$71.5K
ESTC icon
1318
Elastic
ESTC
$6.37B
$1.67M ﹤0.01%
24,670
-2,523
-9% -$184K
SGMO
1319
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.67M ﹤0.01%
402,135
APOG icon
1320
Apogee Enterprises
APOG
$855M
$1.66M ﹤0.01%
42,433
-3,983
-9% -$170K
LEA icon
1321
Lear
LEA
$7.26B
$1.65M ﹤0.01%
13,128
-581
-4% -$76.6K
ITRI icon
1322
Itron
ITRI
$3.76B
$1.64M ﹤0.01%
33,251
+330
+1% +$16.4K
TT icon
1323
Trane Technologies
TT
$107B
$1.64M ﹤0.01%
12,662
-482
-4% -$66.7K
LDOS icon
1324
Leidos
LDOS
$14.5B
$1.63M ﹤0.01%
16,163
+1,057
+7% +$110K
MTD icon
1325
Mettler-Toledo International
MTD
$27B
$1.62M ﹤0.01%
1,410
+108
+8% +$136K

Similar funds

Macquarie Group's Q2 2022 Portfolio in Review

As of Q2 2022, Macquarie Group held 2,672 positions worth $89.1B, up 67,641% from $131M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Macquarie Group withdrew a net $3.22B in Q2 2022, closing 108 positions and reducing 853 holdings. Its most notable exit was Healthcare Realty, an estimated $10.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in Petco worth $56.3M.

  • Macquarie Group's largest Q2 2022 buy was Petco: 3,818,489 shares worth $56.3M.
  • Macquarie Group added most to Hologic in Q2 2022, an estimated $324M increase.
  • Macquarie Group's biggest Q2 2022 reduction was Microsoft, cutting an estimated $504M.
  • Macquarie Group fully exited Healthcare Realty in Q2 2022, selling an estimated $10.8M.
  • Macquarie Group's ten largest holdings make up 12% of its $89.1B portfolio in Q2 2022.
  • Macquarie Group opened 86 new positions and closed 108 in Q2 2022.
  • Macquarie Group's portfolio value rose 67,641% quarter-over-quarter to $89.1B.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.